73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Infections from a diarrhea-causing parasite are on the rise in the UK, but experts aren't quite sure why

Infections from a diarrhea-causing parasite are on the rise in the UK, but experts aren't quite sure why

by Paul Hunter,The ConversationLaboratory notifications of Cryptosporidium species in England, Wales and Northern Ireland, by week of specimen, 2023. Credit:Eurosurveillance(2023). D

Infections from a diarrhea-causing parasite are on the rise in the UK, but experts aren't quite sure why

by Paul Hunter,The ConversationLaboratory notifications of Cryptosporidium species in England, Wales and Northern Ireland, by week of specimen, 2023. Credit:Eurosurveillance(2023). D
Drug combination provides a one-two punch attack against colorectal cancer

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the
Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of

Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of
New report presents a global plan to combat prostate cancer

New report presents a global plan to combat prostate cancer

by University of Miami Leonard M. Miller School of MedicineCredit: Unsplash/CC0 Public DomainAnnual prostate cancer cases worldwide are projected to double by the year 2040, and annual deaths are

New report presents a global plan to combat prostate cancer

by University of Miami Leonard M. Miller School of MedicineCredit: Unsplash/CC0 Public DomainAnnual prostate cancer cases worldwide are projected to double by the year 2040, and annual deaths are
Drug combination discovery may extend life expectancy of children with brain cancer

Drug combination discovery may extend life expectancy of children with brain cancer

by Newcastle UniversityCredit: Unsplash/CC0 Public DomainNewcastle and Hunter-based researchers have discovered a drug combination that could improve the life expectancy of children with brain ca

Drug combination discovery may extend life expectancy of children with brain cancer

by Newcastle UniversityCredit: Unsplash/CC0 Public DomainNewcastle and Hunter-based researchers have discovered a drug combination that could improve the life expectancy of children with brain ca
Specific components of the tumor immune microenvironment may affect responses to BCMA CAR T-cell therapy

Specific components of the tumor immune microenvironment may affect responses to BCMA CAR T-cell therapy

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer marker

Specific components of the tumor immune microenvironment may affect responses to BCMA CAR T-cell therapy

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer marker
Resistance of mammary fibrosis to immune checkpoint therapy linked to macrophage infiltration, Wnt pathway expression

Resistance of mammary fibrosis to immune checkpoint therapy linked to macrophage infiltration, Wnt pathway expression

by Impact Journals LLCWnt pathway expression in tumors from NeuT/ATTAC mice. Credit: 2022 Yuan et al.A new research paper titled "Resistance of MMTV-NeuT/ATTAC mice to anti-PD-1 immune checkpoint

Resistance of mammary fibrosis to immune checkpoint therapy linked to macrophage infiltration, Wnt pathway expression

by Impact Journals LLCWnt pathway expression in tumors from NeuT/ATTAC mice. Credit: 2022 Yuan et al.A new research paper titled "Resistance of MMTV-NeuT/ATTAC mice to anti-PD-1 immune checkpoint
How oncologists can ethically navigate the 'Right-To-Try' drug law

How oncologists can ethically navigate the 'Right-To-Try' drug law

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainThe 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs

How oncologists can ethically navigate the 'Right-To-Try' drug law

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainThe 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs
Sharp pain in your feet? Researchers test promising therapy for cancer patients' neuropathy

Sharp pain in your feet? Researchers test promising therapy for cancer patients' neuropathy

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainA wearable, app-controlled wireless device that stimulates nerves in the legs and feet may help individuals

Sharp pain in your feet? Researchers test promising therapy for cancer patients' neuropathy

by Leslie Orr,University of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainA wearable, app-controlled wireless device that stimulates nerves in the legs and feet may help individuals
Minimal residual disease negativity predicts time to next treatment in multiple myeloma

Minimal residual disease negativity predicts time to next treatment in multiple myeloma

by Elana GotkineFor patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (NGS) is predictive of longer time to next treatment (TTN

Minimal residual disease negativity predicts time to next treatment in multiple myeloma

by Elana GotkineFor patients with multiple myeloma (MM), minimal residual disease (MRD) negativity determined using next-generation sequencing (NGS) is predictive of longer time to next treatment (TTN
Metastatic cancer gorges on fructose in the liver

Metastatic cancer gorges on fructose in the liver

by Duke UniversityCredit: CC0 Public DomainBiomedical engineers at Duke University have demonstrated that metastatic cancer cells can reprogram their metabolism to thrive in new organs. Specifica

Metastatic cancer gorges on fructose in the liver

by Duke UniversityCredit: CC0 Public DomainBiomedical engineers at Duke University have demonstrated that metastatic cancer cells can reprogram their metabolism to thrive in new organs. Specifica
Test can predict how people with leukaemia will respond to chemotherapy

Test can predict how people with leukaemia will respond to chemotherapy

by BloodwiseCredit: CC0 Public DomainThe first test to quickly and accurately predict how people will respond to standard treatment for the most common type of leukaemia has been developed at Cardiff

Test can predict how people with leukaemia will respond to chemotherapy

by BloodwiseCredit: CC0 Public DomainThe first test to quickly and accurately predict how people will respond to standard treatment for the most common type of leukaemia has been developed at Cardiff